Graphene oxide-templated biomineralization nanosystem enables multi-drug loading and controllable release
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Bone Tissue Engineering Materials · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Jin H, Wang L, Bernards R (2023) Rational combinations of targeted cancer therapies: background, advances and challenges. Nat Rev Drug Discov 22:213–234. https://doi.org/10.1038/s41573-022-00615-z10.1038/s41573-022-00615-z ↗
2. Sun L, Zhao P, Chen M, Leng J, Luan Y, Du B, Yang J, Yang Y, Rong R (2022) Taxanes prodrug-based nanomedicines for cancer therapy. J Control Release 348:672–691. https://doi.org/10.1016/j.jconrel.2022.06.00410.1016/j.jconrel.2022.06.004 ↗
3. Miller AL, Garcia PL, Yoon KJ (2020) Developing effective combination therapy for pancreatic cancer: an overview. Pharmacol Res 155:104740. https://doi.org/10.1016/j.phrs.2020.10474010.1016/j.phrs.2020.104740 ↗
4. Bashraheel SS, Domling A, Goda SK (2020) Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine. Biomed Pharmacother 125:110009. https://doi.org/10.1016/j.biopha.2020.11000910.1016/j.biopha.2020.110009 ↗
5. Jaleel JA, Pramod K (2018) Artful and multifaceted applications of carbon dot in biomedicine. J Control Release 269:302–321. https://doi.org/10.1016/j.jconrel.2017.11.02710.1016/j.jconrel.2017.11.027 ↗
6. Cring MR, Sheffield VC (2022) Gene therapy and gene correction: targets, progress, and challenges for treating human diseases. Gene Ther 29:3–12. https://doi.org/10.1038/s41434-020-00197-810.1038/s41434-020-00197-8 ↗
7. Chen L, Ji F, Bao Y, Xia J, Guo L, Wang J, Li Y (2017) Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy. Mater Sci Eng C Mater Biol Appl 70:418–429. https://doi.org/10.1016/j.msec.2016.09.01910.1016/j.msec.2016.09.019 ↗
8. Meng QY, Cong HL, Hu H, Xu FJ (2020) Rational design and latest advances of codelivery systems for cancer therapy. Mater Today Bio 7:100056. https://doi.org/10.1016/j.mtbio.2020.10005610.1016/j.mtbio.2020.100056 ↗
9. Xiao Y, Pang YX, Yan Y, Qian P, Zhao H, Manickam S, Wu T, Pang CH (2023) Synthesis and functionalization of graphene materials for biomedical applications: recent advances, challenges, and perspectives. Adv Sci (Weinh) 10:e2205292. https://doi.org/10.1002/advs.20220529210.1002/advs.202205292 ↗
10. Lima-Sousa R, de Melo-Diogo D, Alves CG, Costa EC, Ferreira P, Louro RO, Correia IJ (2018) Hyaluronic acid functionalized green reduced graphene oxide for targeted cancer photothermal therapy. Carbohydr Polym 200:93–99. https://doi.org/10.1016/j.carbpol.2018.07.06610.1016/j.carbpol.2018.07.066 ↗
11. Shen JW, Li J, Dai J, Zhou M, Ren H, Zhang L, Hu Q, Kong Z, Liang L (2020) Molecular dynamics study on the adsorption and release of doxorubicin by chitosan-decorated graphene. Carbohydr Polym 248:116809. https://doi.org/10.1016/j.carbpol.2020.11680910.1016/j.carbpol.2020.116809 ↗
12. Xu C, Hong H, Lee Y, Park KS, Sun M, Wang T, Aikins ME, Xu Y, Moon JJ (2020) Efficient lymph node-targeted delivery of personalized cancer vaccines with reactive oxygen species-inducing reduced graphene oxide nanosheets. ACS Nano 14:13268–13278. https://doi.org/10.1021/acsnano.0c0506210.1021/acsnano.0c05062 ↗
13. Anirudhan TS, Chithra Sekhar V, Athira VS (2020) Graphene oxide based functionalized chitosan polyelectrolyte nanocomposite for targeted and pH responsive drug delivery. Int J Biol Macromol 150:468–479. https://doi.org/10.1016/j.ijbiomac.2020.02.05310.1016/j.ijbiomac.2020.02.053 ↗
14. Jawaid M, Bouhfid R, Qaiss A e K (2019) Functionalized graphene nanocomposites and their derivatives
15. Min H, Qi Y, Zhang Y, Han X, Cheng K, Liu Y, Liu H, Hu J, Nie G, Li Y (2020) A graphdiyne oxide-based iron sponge with photothermally enhanced tumor-specific Fenton chemistry. Adv Mater 32:e2000038. https://doi.org/10.1002/adma.20200003810.1002/adma.202000038 ↗
16. Li Y, Wang Y, Shang H, Wu J (2022) Graphene quantum dots modified upconversion nanoparticles for photodynamic therapy. Int J Mol Sci 23:12558. https://doi.org/10.3390/ijms23201255810.3390/ijms232012558 ↗
17. He H, Li Z, Li K, Lei G, Guan X, Zhang G, Zhang F, Fan X, Peng W, Li Y (2019) Bifunctional graphene-based metal-free catalysts for oxidative coupling of amines. ACS Appl Mater Interfaces 11:31844–31850. https://doi.org/10.1021/acsami.9b0874110.1021/acsami.9b08741 ↗
18. Vincent M, de Lázaro I, Kostarelos K (2017) Graphene materials as 2D non-viral gene transfer vector platforms. Gene Ther 24:123–132. https://doi.org/10.1038/gt.2016.7910.1038/gt.2016.79 ↗
19. Adepu S, Ramakrishna S (2021) Controlled drug delivery systems: current status and future directions. Molecules 26:5905. https://doi.org/10.3390/molecules2619590510.3390/molecules26195905 ↗
20. Romero MP, Buzza HH, Stringasci MD, Estevão BM, Silva CCC, Pereira-da-Silva MA, Inada NM, Bagnato VS (2021) Graphene oxide theranostic effect: conjugation of photothermal and photodynamic therapies based on an in vivo demonstration. Int J Nanomedicine 16:1601–1616. https://doi.org/10.2147/IJN.S28741510.2147/IJN.S287415 ↗
21. Yao S, Jin B, Liu Z, Shao C, Zhao R, Wang X, Tang R (2017) Biomineralization: from material tactics to biological strategy. Adv Mater 29:1605903. https://doi.org/10.1002/adma.20160590310.1002/adma.201605903 ↗
22. Huang A, Tong L, Kou X, Gao R, Li ZW, Huang S, Zhu F, Chen G, Ouyang G (2023) Structural and functional insights into the biomineralized zeolite imidazole frameworks. ACS Nano 17:24130–24140. https://doi.org/10.1021/acsnano.3c0911810.1021/acsnano.3c09118 ↗
23. Huang X, Andina D, Ge J, Labarre A, Leroux JC, Castagner B (2017) Characterization of calcium phosphate nanoparticles based on a PEGylated chelator for gene delivery. ACS Appl Mater Interfaces 9:10435–10445. https://doi.org/10.1021/acsami.6b1592510.1021/acsami.6b15925 ↗
24. Levingstone TJ, Herbaj S, Redmond J, McCarthy HO, Dunne NJ (2020) Calcium phosphate nanoparticles-based systems for RNAi delivery: applications in bone tissue regeneration. Nanomaterials (Basel) 10:146. https://doi.org/10.3390/nano1001014610.3390/nano10010146 ↗
25. Bi YG, Lin ZT, Deng ST (2019) Fabrication and characterization of hydroxyapatite/sodium alginate/chitosan composite microspheres for drug delivery and bone tissue engineering. Mater Sci Eng C Mater Biol Appl 100:576–583. https://doi.org/10.1016/j.msec.2019.03.04010.1016/j.msec.2019.03.040 ↗
26. Hoffmann M, Gerlach S, Hoffmann C, Richter N, Hersch N, Csiszár A, Merkel R, Hoffmann B (2022) PEGylation and folic-acid functionalization of cationic lipoplexes-improved nucleic acid transfer into cancer cells. Front Bioeng Biotechnol 10:1066887. https://doi.org/10.3389/fbioe.2022.106688710.3389/fbioe.2022.1066887 ↗
27. Udenfriend S, Stein S, Böhlen P, Dairman W, Leimgruber W, Weigele M (1972) Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science 178(4063):871–2. https://doi.org/10.1126/science.178.4063.87110.1126/science.178.4063.871 ↗
28. Piñeiro GA, Vega SM, Mutton G, Tristán F, Meneses RD, Semetey V (2021) Insights in the chemical composition of graphene oxide via a simple and versatile fluorescent labelling method. ChemNanoMat 7(7):842–850. https://doi.org/10.1002/cnma.20210012110.1002/cnma.202100121 ↗
29. Mousazadeh H, Bonabi E, Zarghami N (2022) Stimulus-responsive drug/gene delivery system based on polyethylenimine cyclodextrin nanoparticles for potential cancer therapy. Carbohyd Polym 276:118747. https://doi.org/10.1016/j.carbpol.2021.11874710.1016/j.carbpol.2021.118747 ↗
30. Park K, Lee MY, Kim KS, Hahn SK (2010) Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate. Biomaterials 31(19):5258–5265. https://doi.org/10.1016/j.biomaterials.2010.03.01810.1016/j.biomaterials.2010.03.018 ↗
31. Zhao M, Zhu T, Chen J, Cui Y, Zhang X, Lee RJ, Sun F, Li Y, Teng L (2021) PLGA/PCADK composite microspheres containing hyaluronic acid-chitosan siRNA nanoparticles: a rational design for rheumatoid arthritis therapy. Int J Pharm 596:120204. https://doi.org/10.1016/j.ijpharm.2021.12020410.1016/j.ijpharm.2021.120204 ↗
32. Zhang T, Huang Y, Ma X, Gong N, Liu X, Liu L, Ye X, Hu B, Li C, Tian JH, Magrini A, Zhang J, Guo W, Xing JF (2018) Fluorinated oligoethylenimine nanoassemblies for efficient siRNA-mediated gene silencing in serum-containing media by effective endosomal escape. Nano Lett 18(10):6301–6311. https://doi.org/10.1021/acs.nanolett.8b0255310.1021/acs.nanolett.8b02553 ↗
33. Xu J, Zhang S, Machado A, Lecommandoux S, Sandre O, Gu F, Colin A (2017) Controllable microfluidic production of drug-loaded PLGA nanoparticles using partially water-miscible mixed solvent microdroplets as a precursor. Sci Rep 7(1):4794. https://doi.org/10.1038/s41598-017-05184-510.1038/s41598-017-05184-5 ↗
34. Mohan P, Rapoport N (2010) Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking. Mol Pharm 7(6):1959–1973. https://doi.org/10.1021/mp100269f10.1021/mp100269f ↗
35. Bansal R, Singh R, Kaur K (2021) Quantitative analysis of doxorubicin hydrochloride and arterolane maleate by mid IR spectroscopy using transmission and reflectance modes. BMC chemistry 15(1):27. https://doi.org/10.1186/s13065-021-00752-310.1186/s13065-021-00752-3 ↗
36. Cheng Q, Du L, Meng L, Han S, Wei T, Wang X, Wu Y, Song X, Zhou J, Zheng S, Huang Y, Liang XJ (2016) The promising nanocarrier for doxorubicin and siRNA co-delivery by PDMAEMA-based amphiphilic nanomicelles. ACS Appl Mater Interfaces 8(7):4347–4356. https://doi.org/10.1021/acsami.5b1178910.1021/acsami.5b11789 ↗
37. Jafarkhani M, Salehi Z, Nematian T (2018) Preparation and characterization of chitosan/graphene oxide composite hydrogels for nerve tissue engineering. Mater Today Proc 5:15620–1562810.1016/j.matpr.2018.04.171 ↗
38. Ma N, Liu J, He W, Li Z, Luan Y, Song Y, Garg S (2017) Folic acid-grafted bovine serum albumin decorated graphene oxide: an efficient drug carrier for targeted cancer therapy. J Colloid Interface Sci 490:598–607. https://doi.org/10.1016/j.jcis.2016.11.09710.1016/j.jcis.2016.11.097 ↗
39. Zhang C, Liu Z, Zheng Y, Geng Y, Han C, Shi Y, Sun H, Zhang C, Chen Y, Zhang L, Guo Q, Yang L, Zhou X, Kong L (2018) Glycyrrhetinic acid functionalized graphene oxide for mitochondria targeting and cancer treatment in vivo. Small 14:1703306. https://doi.org/10.1002/smll.20170330610.1002/smll.201703306 ↗
40. Yin F, Hu K, Chen Y, Yu M, Wang D, Wang Q, Yong KT, Lu F, Liang Y, Li Z (2017) SiRNA delivery with PEGylated graphene oxide nanosheets for combined photothermal and genetherapy for pancreatic cancer. Theranostics 7:1133–1148. https://doi.org/10.7150/thno.1784110.7150/thno.17841 ↗
41. Chau NDQ, Reina G, Raya J, Vacchi IA, Ménard-Moyon C, Nishina Y, Bianco A (2017) Elucidation of siRNA complexation efficiency by graphene oxide and reduced graphene oxide. Carbon 122:643–652. https://doi.org/10.1016/j.carbon.2017.07.01610.1016/j.carbon.2017.07.016 ↗
42. Karki N, Tiwari H, Tewari C, Rana A, Pandey N, Basak S, Sahoo NG (2020) Functionalized graphene oxide as a vehicle for targeted drug delivery and bioimaging applications. J Mater Chem B 8:8116–8148. https://doi.org/10.1039/d0tb01149e10.1039/d0tb01149e ↗
43. Wang L, Yu D, Dai R, Fu D, Li W, Guo Z, Cui C, Xu J, Shen S, Ma K (2019) PEGylated doxorubicin cloaked nano-graphene oxide for dual-responsive photochemical therapy. Int J Pharm 557:66–73. https://doi.org/10.1016/j.ijpharm.2018.12.03710.1016/j.ijpharm.2018.12.037 ↗
44. Tian Q, Zhang CN, Wang XH, Wang W, Huang W, Cha RT, Wang CH, Yuan Z, Liu M, Wan HY, Tang H (2010) Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery. Biomaterials 31(17):4748–4756. https://doi.org/10.1016/j.biomaterials.2010.02.04210.1016/j.biomaterials.2010.02.042 ↗
45. Wang QS, Gao LN, Zhu XN, Zhang Y, Zhang CN, Xu D (2019) Co-delivery of glycyrrhizin and doxorubicin by alginate nanogel particles attenuates the activation of macrophage and enhances the therapeutic efficacy for hepatocellular carcinoma. Theranostics 9(21):6239–6255. https://doi.org/10.7150/thno.35972.eCollection10.7150/thno.35972.eCollection ↗
46. Zhang C, Wang W, Liu T, Wu Y, Guo H, Wang P, Tian Q, Wang Y, Yuan Z (2012) Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy. Biomaterials 33(7):2187–2196. https://doi.org/10.1016/j.biomaterials.2011.11.04510.1016/j.biomaterials.2011.11.045 ↗